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Blood safety with respect to infectious complications
has reached very high standards. Nevertheless,
reports on transfusion-associated morbidity and
mortality gain momentum. Multidisciplinary patient
blood management programs can minimize
unnecessary exposure to allogeneic blood products
by strengthening and conserving patients’ own
resources. This article outlines concepts designed to
maintain hemoglobin concentration, to optimize
hemostasis, and to minimize blood loss in ICUs. These
measures prevent or at least alleviate hospital-acquired
anemia, reduce the need for blood transfusions, and
therefore have great potential to improve patient safety
and medical outcome.omy and laboratory blood sampling to monitor coagula-
tion, organ function, and acid–base status or to screenIntroduction
Blood is the most precious and eclectic of fluids. Blood
transports oxygen and nutrients throughout the body,
heals our wounds, connects our organs, and protects us
from dangerous pathogens; it is the essence through
which we can remain healthy and able. Not surprisingly,
the shortage of blood and especially of the associated
hemoglobin - manifested clinically as anemia - negatively
affects patient outcomes [1-5]. Anemia is a very common
phenomenon, particularly among critically ill patients.
Approximately two thirds of the patients already show a
hemoglobin concentration of below 120 g/L on admission
to the ICU, and after 1 week 97% are anemic [3,5,6]. This
condition often results from a combination of nutritional
deficiency, hemolysis, myelosuppression, renal insuffi-
ciency, and comorbidities. Unfortunately, there are no im-
mediate remedies for anemia without side effects. Blood
safety with respect to infectious complications might have
reached very high standards [7], but reports on
transfusion-associated morbidity and mortality continue to
abound. Evidence increasingly suggests that the transfusion* Correspondence: kai.zacharowski@kgu.de
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2014of even a single allogeneic red blood cell (RBC) unit can be
associated with increased morbidity and mortality because
of infectious, immunological, pulmonary, and thrombo-
embolic complications [8-11]. The creation of a suitable
synthetic blood mimetic has long been sought after, yet this
goal remains elusive.
This leaves practitioners facing a dilemma. On one
hand, anemia should be reconciled in order for the body
to function at optimal levels, yet the one immediate
solution of transfusing allogeneic RBCs may harm the
patient further by inducing additional adverse events.
This dilemma is arguably most pressing in the ICU
because patients are sickest and the close surveillance of
the patients requires collection of blood for testing.
However, this renders patients even more vulnerable to
anemia. Shockingly, weekly blood loss due to phlebot-
for nosocomial infections has been reported to range
from 340 to 660 mL in ICU patients [12,13]. Similar
observations prompted John F Burnum in 1986 to pro-
vocatively refer to physicians as ‘medical vampires’ [14].
Despite our good intentions, we as medical care
providers often add considerably to the development of
anemia by close laboratory surveillance and other blood-
shedding therapeutic measures, such as dialysis.
Particularly in the setting of ICUs, a multicomponent
strategy to prevent or at least ameliorate hospital-
acquired anemia is needed. There are many angles from
which we can tackle this issue while possibly improving
outcomes and minimizing additional complications.
Areas where a new standard of care could be most
beneficial include the improvement of diagnostic and
therapeutic procedures and the optimization of coagula-
tion management and hemotherapy. Together, we should
seek every possibility to reduce our ‘appetite’ for blood
and move from being ‘medical vampires’ to ‘medical
mosquitoes’.Ltd. The licensee has exclusive rights to distribute this article, in any medium, for
time, the article is available under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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The Sepsis Occurrence in Acutely Ill Patients study re-
ported a positive correlation between severity of organ
dysfunction, the number of blood draws, and the total
volume drawn [5]. Admittedly, more iatrogenic blood
loss was recorded in the sicker patient groups compared
with relatively healthier ones, and this may confound the
results as these patients were per se more likely to suffer
from organ dysfunction due to their underlying condi-
tion. Nevertheless, it appears that iatrogenic blood loss
has a negative impact on patient outcomes and therefore
offers an area with great potential for improvement.
However, there is significant variation between ICUs:
demographic and clinical characteristics of patients, varying
surgical partners, local standards of care, and laboratory
performances are but a few factors that have a large impact
on the volume of blood losses. An informative first step is
therefore for each hospital to keep a record on the fre-
quency and volume of blood drawings for each patient. A
simple visualization is a solid foundation to build upon in
order to design methods to effectively reduce blood losses.
It can also serve as a baseline to quantify and compare the
effect of tailor-made solutions in instances in which a
common deficiency is identified at a regional or even
national level.
The frequency, volume, and process of blood drawings
are rational first steps for consideration in constructing bet-
ter standards of care. Firstly, scattershot laboratory testing
should be avoided by carefully evaluating and streamlining
the commonly used practice parameters. Establishing a task
force of interdisciplinary local experts representing critical
care medicine, surgery, internal medicine, infectious dis-
eases, neurology, laboratory medicine/microbiology, and
nursing staff is one approach to this. This task force should
establish a consensus on parameters and frequency of la-
boratory testing in common situations to guide clinical
practice. The consensus could be based upon evidence-
based recommendations and expert opinion. An example
for this is a utilization management intervention, which re-
duced unnecessary testing in a coronary care unit estab-
lished by a multidisciplinary team at Massachusetts
General Hospital (Boston, MA, USA) [15]. The team
viewed the routine determination of ‘extended’ chemistries,
such as calcium, magnesium, and phosphorus, as unsub-
stantiated practice in coronary care patients. The team de-
veloped guidelines and computerized order template
designs discouraging the routine measurements of these
electrolytes and also of arterial blood gases (ABGs) in pa-
tients not receiving ventilatory support. Tests for sodium,
potassium, chloride, and complete blood counts were rec-
ommended to be ordered only once per day. Analysis of
ABG measurement was recommended only after signifi-
cant changes in minute ventilation, fall in oxygen satur-
ation, or significant changes in clinical condition. Wangand colleagues [15] specifically emphasized that blood gases
did not have to be assessed with every change in ventilator
setting. They were thus able to demonstrate a significant re-
duction in routine testing without change in clinical out-
comes and saw scope for further reduction. However, the
study was not powered to assess differences in clinical out-
comes, historical controls were used, and the measures of
severity of illness were imprecise.
Another example to improve physician test ordering
might be a guideline on the evaluation of patients who de-
velop early postoperative fever in the ICU [16]. Fever is a
common phenomenon during the initial 48 hours after sur-
gery and usually non-infectious in origin under the precon-
dition that sterility was kept and no aspiration occurred.
The guideline by O’Grady and colleagues [16] therefore
recommends caution with regard to taking blood cultures
in the work-up of early postoperative fever.
Recommendations on the frequency of laboratory testing
should also take into account the half-life and appropriate-
ness of clinical biomarkers: C-reactive protein (CRP), for in-
stance, has a half-life of 19 hours and cannot be
recommended as an aid to the initiation or discontinuation
of any antibiotic in adults, as described by Dupuy and col-
leagues [17]. CRP values can never be diagnostic on their
own and can be interpreted only at the bedside, in full
knowledge of all other clinical and pathological results [18].
Besides, laboratory tests should be repeated only if indi-
cated: clinicians should refrain from using prepackaged or-
derings and move on to hand-picked and also consider the
inherent standard deviation of laboratory findings when or-
dering tests. In this regard, physicians should be mindful
that false-positive results need control and therefore should
order only the minimum requirement, thus reducing over-
all burden on the health-care system and reducing the risk
of negative outcomes for the patient. We believe that there
is great savings potential of restrictive versus standard
laboratory testing.
Moreover, the process of blood drawing itself might offer
scope for improvement. We encourage the introduction of
in-line blood sampling devices, which can also be combined
with chemistry monitors. Widness and colleagues [19], for
example, could reduce cumulative phlebotomy loss by one
fourth in a randomized, controlled, prospective trial on
preterm infants: monitor group (n = 46) and control group
(n = 47). An in-line bedside monitor was used that with-
draws blood through an arterial catheter; analyzes blood
gases and sodium, potassium, and hematocrit levels; and
returns the sample to the patient. Through the use of in-
line blood sampling devices, the same quality of care can be
maintained without any increased risk of infection com-
pared with standard arterial and venous lines while less
blood is wasted [12,20]. We would argue that in-line blood
sampling devices represent a realistic and effective tool in
saving patients’ blood.
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ments may also reduce blood wastage. The blood diagnos-
tics unit at the University Hospital Frankfurt, Germany,
for instance, requires specimens of only 30 μL for the
quantification of procalcitonin; the dead space volume
needed to prime the system, however, is 300 μL. Techno-
logical innovations in the future may further reduce dead
space volume requirements, and the improved preserva-
tion of blood specimens for potential subsequent use
would be another beneficial area to explore. The sensible
use of analytical chemistry techniques and, where applic-
able, the introduction of pediatric vials (having a capacity
of less than 100 μL) should be considered. One study has
shown that using pediatric blood collection tubes nearly
halved the blood loss associated with diagnostic testing
(reduction of 47%) without compromising laboratory test
procedures and test quality [21]. Figure 1 illustrates adult
(‘vampire’s appetite’) versus such pediatric (‘mosquito’s ap-
petite’) test tubes. In this regard, using smaller tubes may
have the potential to reduce the severity of phlebotomy-
induced anemia in adults. However, the drawback of this is
that smaller test tubes bind more human resources as they
usually require manual handling, thereby increasing costs
and potentially delaying analysis. Point-of-care (POC)
microanalysis such as bedside tests, on the other hand, also
often requires less than 500-μL specimens and has the add-
itional advantage of short turnaround times for results, re-
ducing staff time requirements. However, the nearness of
the tests might increase the number of tests done.
Additionally, non-invasive tools for hemodynamic mon-
itoring should be used wherever possible as indwelling
catheters have been shown to increase blood testing [22].
Transcutaneous measurements of hemoglobin can also be
considered, although results from non-invasive analysisFigure 1 Appetite for blood: medical vampire or medical mosquito? Imight deviate from actual values which render these
methods potentially hazardous [23,24]. Further factors
such as vasopressor therapy may interfere and represent
another serious limitation for non-invasive hemoglobin
monitoring in many ICU patients [25].
Blood-sparing techniques
Continuous dialysis is a common requirement in critical
care patients and necessitates sufficient anticoagulation
to prevent blood clotting: premature clotting of the dia-
lysis circuit leads to increased blood loss for the patient.
On the other hand, anticoagulation itself inherently in-
creases bleeding risk. One therapeutic strategy that ex-
tends filter lifetime without increasing the risk of
bleeding is the use of citrate-anticoagulation during dia-
lysis. Citrate is administered in the extracorporeal circuit
and chelates the calcium required in the coagulation
cascade. It extends circuit survival time and filter life-
time [26,27] and furthermore is associated with a signifi-
cant decrease in bleeding - relative risk (RR) 0.34, 95%
CI 0.17 to 0.65 - compared with standard anticoagula-
tion with heparin [28]. However, additional equipment
and training of staff are required initially. Once citrate-
anticoagulated dialysis is implemented, complication
rates are low, making initial investments on monetary
and human resources worthwhile in our view.
Cell salvage is another possibility which can be explored.
Post-operative blood recovery techniques using cell savers
are not applicable in many ICU patients but may be useful
in selected cases with the critically ill. In particular, cell
salvage should be one of the main cornerstones within the
first hours after major surgery in coagulopathic cardiac
surgery patients with increased blood loss in order to re-
duce the need for allogeneic RBC transfusion in ICUs.llustration by Pia Ockelmann.
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Hemostatic abnormalities are common among critically
ill patients and often are of multifactorial origin [29].
Treatment decisions are increasingly aided by bedside
coagulation monitoring, which provides reliable and fast
testing of the overall hemostatic function. Goal-directed
algorithms based on results from thrombelastography
and rotational thromboelastometry have been shown to
reliably regulate coagulopathy in studies on trauma and
cardiac patients [30]. However, owing to the nature of
diseases encountered in ICUs, interventions that are
successful in other settings may not be relevant in the
ICU setting. Furthermore, the costs of acquisition and
provision of trained staff are high. But although studies
on POC-guided hemotherapy algorithms in the treat-
ment of critically ill patients are still pending and initial
costs may be a deterrent, the potential to curtail blood
losses is high. Coagulation management ideally should
be based on a combination of aggregometric and visco-
elastic diagnostic methods integrated into an algorithm
already validated in other medical settings. The algo-
rithm should emphasize the need to maintain optimal
hemostatic conditions with normal pH, temperature,
and calcium levels. Furthermore, it should include anti-
fibrinolytic agents such as tranexamic acid and conclude
with the use of recombinant activated factor VII in se-
lected cases refractory to standard treatment [31,32].
This algorithm should also give an overview of indica-
tions for adequate hemotherapy.
RBC transfusion is a common intervention in ICU
patients; approximately one third of critically ill patients
receive a blood transfusion during their stay in the ICU
[33]. However, RBC transfusions have been associated
with worse outcomes in several populations of patients,
including critically ill patients [3,5,34]. This set off a shift
in transfusion policy toward a more restrictive approach
encompassing lower transfusion thresholds in the critic-
ally ill [35]. Most importantly, it has been recognized that
hemotherapy should be individualized in order to carefully
balance the risks of allogeneic blood products with the
risks of low hemoglobin levels in each single case. Pre-
sumably, not only inter-individual but also intra-individual
variation exists in the tolerance toward anemia dependingTable 1 Measures to spare patient blood
Phlebotomy losses Coagulation manageme
• Quantify sampling volume and frequency • Maintain optimal hemos
temperature)
• Critically assess parameters ordered • Algorithm-based hemot
• Microchemistry techniques, possibly pediatric
vials
• Point-of-care bedside tests
• In-line blood sampling deviceson metabolic activity, volume status, physiological reserve,
dynamics of the anemia, and other health issues. Gener-
ally, normovolemic anemia is better tolerated than hypo-
volemic anemia and chronic anemia (for instance, due to
sepsis) is better tolerated than acute anemia in cases of se-
vere uncontrolled bleeding. Therefore, transfusion deci-
sions should be based on both symptoms as well as
laboratory results such as hemoglobin concentration.
Several prospective studies on restrictive versus liberal
transfusion strategies in critically ill patients exist. How-
ever, there is little evidence on safe transfusion strategies
for patients with cardiovascular diseases, causing a lot of
insecurity in the care of such patients [36,37]. The TRICC
(Transfusion Requirements in Critical Care) trial showed
in 838 ICU patients that a restrictive transfusion threshold
(hemoglobin (Hb) trigger 70 g/L, target 70 to 90 g/L)
compared to a liberal one (Hb trigger 100 g/L, target 100
to 120 g/L) is at least as effective [38]. However, the trial
did not enroll patients with anemia, ischemic heart dis-
ease, or active bleeding. Walsh and colleagues [39] en-
rolled 100 ventilated ICU patients in a prospective,
randomized study and found a non-significant trend to-
ward lower mortality in the restrictive group (Hb trigger
70 g/L, target 71 to 90 g/L) compared with the liberal
group (Hb trigger 90 g/L, target 91 to 110 g/L) 180 days
after randomization (RR 0.68, 95% CI 0.44 to 1.05;
P = 0.073). Thirty-two percent of the patients had ische-
mic heart disease. Surely, more studies will follow and
hopefully provide a more definite answer as to what is safe
for patients with cardiovascular diseases. Finally, we also
recommend a strict ‘single unit policy’ with re-evaluation
of the clinical situation after each unit transfused except
in cases of massive bleeding.
Barriers to implementation
Synthesizing and implementing new standards of care
can be very demanding. Great importance should be
placed on the education of staff to change attitudes to-
ward blood testing. It is vital to address knowledge gaps,
facilitate behaviors, and reduce barriers to them. The
implementation of checklists alongside training ses-
sions of care-providing staff is a highly recommended
tool to maintain adherence to new standards. Table 1nt Further approaches




• Education and checklists
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in critically ill patients. The desired laboratory order-
ing behavior and the employment of blood-sparing
techniques should be reinforced.
However, one should be aware of barriers to implemen-
tation. Further investigation of routine laboratory order-
ings may lead to the conclusion that many orderings are
due primarily to real or perceived medico-legal reasons.
Sincere and powerful fear of medical malpractice claims
may lead to superfluous testing and controlling of more
parameters than medically indicated, in order to minimize
legal risks. Therefore, we would recommend engagement
in introspective and collegial dialogue over professional
practice and litigation risk factors to strive for better pa-
tient outcomes while reducing burdens on the health-care
system. We suggest that inconsistencies be questioned,
diagnostic ordering routines be revised, and anxieties con-
cerning exposure to potential litigation and legal liability
be minimized, for the benefit of our patients’ clinical out-
come. Furthermore, economic arguments seem to increas-
ingly permeate many aspects of hospital routine.
Although these should not guide our medical decision-
making, they are vital to consider as resources are finite.
Personnel and material costs need to be weighed against
potential savings from better patient outcome. Limiting
the use of laboratory order sets will require more attention
from the whole team involved in ICU therapy, in addition
to thoughtful guidance by senior physicians. It is true that
individualized laboratory ordering may be more resource-
intensive and also may require manual processing by the
laboratory staff, especially with the use of smaller pediatric
vials. In our opinion, savoring every drop of blood even
has the potential to reduce costs. This is applicable both
directly to blood transfusion units and to the wider eco-
nomic impact of associated adverse events, from both
hospital-acquired anemia and allogeneic blood transfu-
sions [40,41]: delayed wound healing, nosocomial infec-
tions, renal insufficiency, and major adverse cardiac
events, to name a few. Therefore, a medico-economic
evaluation of the effects of the implementation of a bundle
of measurements is worthwhile and indeed may favor the
improved standards of care described here.
In conclusion, blood use in ICUs can be excessive for
various reasons. Developing and adopting better stan-
dards of care can ameliorate the vicious cycle we find
ourselves in now, in which superfluous testing can result
in iatrogenic anemia that may necessitate subsequent
RBC transfusion. The rate of allogeneic blood transfu-
sions can be further minimized by employing restrictive
transfusion policies. Combined, these multimodal pa-
tient blood management concepts have great potential
to avoid transfusion-related adverse events.
Let us strive to reduce the need for allogeneic blood
transfusions by preserving patients’ blood and transfuseonly when absolutely necessary in order improve the
quality and economy of critical care. Let us savor every
drop just as a mosquito would and not drain blood from
our patients like Dracula!
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